Production Leader Myron Redden Embarks on New Ventures -

Production Leader Myron Redden Embarks on New Ventures

  • commemorative Equilibar

This week Equilibar took a few moments to celebrate the work of Myron Redden, who has guided Equilibar’s production efforts for nine years, almost since the very inception of the company. Over the years, Myron accepted many responsibilities as Equilibar grew from a start-up endeavor into a thriving international technology company. Through it all, he took great pride in the quality of our products and worked steadfastly and cheerfully every day, inspiring us all to do the same.

In recent years, Myron focused on working with vendors to make sure Equilibar always had the exact parts and materials we needed to fulfill customer orders. He developed strong relationships with our valued local partners, including Green’s Machine and Tool, who made what could be the world’s first regulator artwork.

We know the many suppliers, vendors and customers who have worked with Myron for almost a decade will join us in wishing him all the best as he embarks on his next venture in life.

Equilibar President Jeff Jennings, left, and Operations Manager David Reed, right, offer best wishes to Myron Redden.

Equilibar President Jeff Jennings, left, and Operations Manager David Reed, right, offer best wishes to Myron Redden.

 

trophy

Commemorative regulator crafted by Green’s Machine and Tool, one of Equilibar’s excellent local partners.

Categories
Equilibar News
PUK magazine cover with stainless steel device

Journal article focuses on oligonucleotide production using pressure control with built in dampener

Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic.  Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More

Read More